At the 2026 AmSpa Annual Meeting, Acclaro Medical introduces its AuraLux™ fiber laser, focusing on high-impact skin rejuvenation tailored for all patients.

Acclaro Medical launches National 3DMIRACL® Day, showcasing an innovative fiber laser treatment that revolutionizes skin rejuvenation for all skin types.

Acclaro Medical will showcase revolutionary advancements in dermatology with 11 podium presentations on their UltraClear® laser at the upcoming scientific meeting.

Acclaro Medical celebrates the UltraClear® 2910 nm laser's recent achievements, winning three major beauty innovation awards from renowned media outlets, showcasing its revolutionary technology and clinical effectiveness.

Acclaro Medical proudly announces Health Canada's approval for UltraClear, the world's first 2910 nm cold ablative fiber laser, enhancing skin rejuvenation.

Acclaro Medical has raised $23 million in Series B funding, with plans to enhance its revolutionary 2910 nm fiber laser technology, improving skin care solutions and patient experiences.

Acclaro Medical unveils the innovative AuraLux™ Fiber Laser, offering safe and effective skin health solutions with minimal discomfort and downtime.

Acclaro Medical's UltraClear® Laser-Coring™ has been recognized by NewBeauty as the top nonsurgical skin removal procedure for 2025, offering remarkable results.